Pharming (NASDAQ:PHAR) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.01) by 2100 percent. This is a 15.79 percent decrease over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $79.10 million which beat the analyst consensus estimate of $67.73 million by 16.78 percent. This is a 42.30 percent increase over sales of $55.59 million the same period last year.